AzTrials
AzTrials

Social Anxiety DisorderNCT02659436

Imagery-based CBT for Social Anxiety Disorder: Piloting a Treatment Augmentation Protocol

A study testing Verbal-linguistic CBT and Imagery-based CBT in people with Social Anxiety Disorder, run by St. Joseph's Healthcare Hamilton.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this pilot study is to explore whether there is a differential impact of verbal versus imagery-based cognitive behavioural therapy (CBT) as a treatment augmentation strategy for individuals with social anxiety disorder (SAD). Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Social Anxiety Disorder
What is being tested?
Verbal-linguistic CBT and Imagery-based CBT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
No sites listed yet
Study dates
Jan 2016to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Completed eight out of twelve sessions of standard verbal-linguistic group cognitive behavioural therapy for social anxiety disorder
  • Presented with a Social Phobia Inventory (SPIN) score of greater than 19 post-treatment
  • Interested in further treatment

Who cannot join

  • Has another mental health concern of greater importance than social anxiety disorder

About this study

The purpose of this pilot study is to explore whether there is a differential impact of verbal versus imagery-based cognitive behavioural therapy (CBT) as a treatment augmentation strategy for individuals with social anxiety disorder (SAD). Clients who have not demonstrated clinically significant change following group CBT for SAD will receive four additional sessions of either verbal-based CBT or imagery-based CBT. We hypothesize that that individuals who receive imagery-based CBT will experience even stronger improvements and be more satisfied with their treatment than individuals who received traditional verbal-linguistic CBT.

Read the detailed description

Social Anxiety Disorder (SAD) is a debilitating disorder, marked by significant functional impairment and high personal distress for those who suffer. Psychological treatment for SAD has traditionally been verbal-linguistic cognitive behavioural therapy (CBT). However, a significant number of individuals who complete CBT for SAD do not achieve full response and continue to struggle with significant residual symptoms. One innovation that has received attention recently in the literature is using imagery-based CBT as a way to augment treatment outcome in SAD. Results from a pilot and benchmarking study suggest that participants who received imagery-based CBT were more likely to complete treatment than those who received traditional CBT and treatment outcome was strong for both groups, but stronger in the imagery-based CBT group.

However, before re-training hundreds of practitioners in using a completely novel treatment approach, it is important to see if a brief augmentation of traditional CBT programs is effective in producing further change for individuals with residual symptoms after group CBT. It is possible that individuals just require a few more sessions of the same verbal-linguistic CBT to consolidate treatment gains or work on lingering triggers of anxiety. It is also possible that more of the same is not as valuable as offering therapy using a different modality, such as imagery. Therefore, we propose to evaluate a brief imagery-based augmentation of traditional group CBT to explore its effects on further symptom reduction.

Being tested
Verbal-linguistic CBT, Imagery-based CBT
Keywords
Cognitive Behavioural Therapy
Medical subject headings
Phobia, Social

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Verbal-linguistic CBTOther

    Participants will receive 4 sessions of individual therapy focused on traditional cognitive restructuring and exposure therapy.

  • Imagery-based CBTOther

    Participants will receive 4 sessions of individual therapy focused on imagery-based cognitive work and behavioural experiments.

Study groups in NCT02659436
Study groupRoleWhat they receive
Verbal-linguistic CBTActive comparatorParticipants will receive 4 sessions of verbal cognitive restructuring and exposure therapy delivered in an individual therapy format.
Receives: Other: Verbal-linguistic CBT
Imagery-based CBTExperimentalParticipants will receive 4 sessions of imagery-based cognitive work and behavioural experiments delivered in an individual therapy format.
Receives: Other: Imagery-based CBT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Social Phobia Inventory

    Measures social anxiety symptoms

    Measured: This will be administered at the end of the 4 session protocol which will take place approximately 4 -6 weeks after entry into the study.

Secondary outcomes (5)
  1. Vividness of Visual Imagery Questionnaire

    Measures the ability to visualize several visual images

    Measured: This will be administered at the end of the 4 session protocol which will take place approximately 4 -6 weeks after entry into the study.

  2. Homework Adherence Scale

    Measures the quality of homework completion

    Measured: This will be administered at the end of the 4 session protocol which will take place approximately 4 -6 weeks after entry into the study.

  3. Treatment Satisfaction Scale

    Measures the participant's satisfaction with their treatment

    Measured: This will be administered at the end of the 4 session protocol which will take place approximately 4 -6 weeks after entry into the study.

  4. Brief Fear of Negative Evaluation Scale

    Measures fears about being negatively evaluated by others

    Measured: This will be administered at the end of the 4 session protocol which will take place approximately 4 -6 weeks after entry into the study.

  5. Illness Intrusiveness Rating Scale

    Measures how much anxiety interferes with functioning

    Measured: This will be administered at the end of the 4 session protocol which will take place approximately 4 -6 weeks after entry into the study.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2016 (estimated)
  2. Study startJan 2016
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02659436
Sponsor's protocol ID
0986
Status last verified
Dec 2016
First submitted
14 Jan 2016
Last updated
29 Dec 2016
Results posted
No
Data monitoring committee
No

Publications

  • American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th edition). Washington, DC: APA.

  • Antony MM, Roth D, Swinson RP, Huta V, Devins GM. Illness intrusiveness in individuals with panic disorder, obsessive-compulsive disorder, or social phobia. J Nerv Ment Dis. 1998 May;186(5):311-5. doi: 10.1097/00005053-199805000-00008.

    PubMed 9612449
  • Bieling, P.J., Rowa, K., Antony, M.M., Summerfeldt, L.J., & Swinson, R.P. (2001). Factor structure of the Illness Intrusiveness Ratings Scale in patients diagnosed with anxiety disorders. Journal of Psychopathology and Behavioral Assessment, 23, 223-230. doi: 10.1023/A:1012723318964

  • Carleton RN, Collimore KC, Asmundson GJ. Social anxiety and fear of negative evaluation: construct validity of the BFNE-II. J Anxiety Disord. 2007;21(1):131-41. doi: 10.1016/j.janxdis.2006.03.010. Epub 2006 May 3.

    PubMed 16675196
  • Devins GM. Illness intrusiveness and the psychosocial impact of lifestyle disruptions in chronic life-threatening disease. Adv Ren Replace Ther. 1994 Oct;1(3):251-63. doi: 10.1016/s1073-4449(12)80007-0.

    PubMed 7614328
  • Devins GM, Dion R, Pelletier LG, Shapiro CM, Abbey S, Raiz LR, Binik YM, McGowan P, Kutner NG, Beanlands H, Edworthy SM. Structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the Illness Intrusiveness Ratings Scale. Med Care. 2001 Oct;39(10):1097-104. doi: 10.1097/00005650-200110000-00007.

    PubMed 11567172
  • Hackmann A, Clark DM, McManus F. Recurrent images and early memories in social phobia. Behav Res Ther. 2000 Jun;38(6):601-10. doi: 10.1016/s0005-7967(99)00161-8.

    PubMed 10846808
  • Hirsch CR, Clark DM, Mathews A, Williams R. Self-images play a causal role in social phobia. Behav Res Ther. 2003 Aug;41(8):909-21. doi: 10.1016/s0005-7967(02)00103-1.

    PubMed 12880646
  • Holmes EA, Lang TJ, Shah DM. Developing interpretation bias modification as a "cognitive vaccine" for depressed mood: imagining positive events makes you feel better than thinking about them verbally. J Abnorm Psychol. 2009 Feb;118(1):76-88. doi: 10.1037/a0012590.

    PubMed 19222316
  • Leary, M. R. (1983). A brief version of the Fear of Negative Evaluation Scale. Personality and Social Psychology Bulletin, 9, 371-376. doi: 10.1177/0146167283093007

  • McEvoy PM, Saulsman LM. Imagery-enhanced cognitive behavioural group therapy for social anxiety disorder: a pilot study. Behav Res Ther. 2014 Apr;55:1-6. doi: 10.1016/j.brat.2014.01.006. Epub 2014 Feb 7.

    PubMed 24561919
  • McEvoy PM, Erceg-Hurn DM, Saulsman LM, Thibodeau MA. Imagery enhancements increase the effectiveness of cognitive behavioural group therapy for social anxiety disorder: a benchmarking study. Behav Res Ther. 2015 Feb;65:42-51. doi: 10.1016/j.brat.2014.12.011. Epub 2014 Dec 27.

    PubMed 25569339
  • Moscovitch DA, Gavric DL, Merrifield C, Bielak T, Moscovitch M. Retrieval properties of negative vs. positive mental images and autobiographical memories in social anxiety: outcomes with a new measure. Behav Res Ther. 2011 Aug;49(8):505-17. doi: 10.1016/j.brat.2011.05.009. Epub 2011 May 26.

    PubMed 21683343

Questions about this trial

What is this clinical trial studying?

A study testing Verbal-linguistic CBT and Imagery-based CBT in people with Social Anxiety Disorder, run by St. Joseph's Healthcare Hamilton.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Social Phobia Inventory (time frame: This will be administered at the end of the 4 session protocol which will take place approximately 4 -6 weeks after entry into the study.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02659436, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in